BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $100 at Credit Suisse
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $58.99 +2.02%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Credit Suisse analyst Martin Auster lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 (from $102.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,410 at BNP Paribas Exane
- IIFL Finance Ltd (IIFL:IN) PT Raised to INR650 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
